Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution

作者: Elisa Bizzoco , Francesco Lolli , Anna Maria Repice , Bahia Hakiki , Mario Falcini

DOI: 10.1007/S00415-009-5171-X

关键词:

摘要: Neuromyelitis optica spectrum disorder (NMOsd) is a group of demyelinating disorders recently redefined and associated with NMO-IgG/anti-aquaporin 4 antibodies. Because NMOsd unknown prevalence worldwide, we conducted retrospective, cross-sectional study 850 patients hospitalized in North East Tuscany from 1998 to 2006 examine the NMO related among unselected consecutive neurological inflammatory CNS diseases evaluate clinical phenotype identified cases. Clinical data were updated after at least 2 years follow-up. An immunofluorescence technique was used detect NMO-IgG on rat brain tissue. Sera other 828 patients, 65 non-neurological 50 healthy donors served as controls. The 1.5%, MS:NMOsd ratio 42.7. Among 13 77% had long spinal cord lesions, 38% severe optic neuritis 23% or brainstem lesions. Only 56% clinically definite final EDSS score ranged 1 10, mainly depending involvement occurrence. Our findings confirm low Caucasian population. Moreover, this demonstrates an unexpectedly high limited atypical variants disease, not previously documented.

参考文章(19)
Dean, M. Wingerchuk, Neuromyelitis optica: current concepts. Frontiers in Bioscience. ,vol. 9, pp. 834- 840 ,(2004) , 10.2741/1267
B.O. Osuntokun, The pattern of neurological illness in tropical Africa Journal of the Neurological Sciences. ,vol. 12, pp. 417- 442 ,(1971) , 10.1016/0022-510X(71)90110-9
P Waters, Angela Vincent, Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. The International MS Journal. ,vol. 15, pp. 99- 105 ,(2008)
R M Papais-Alvarenga, C M Miranda-Santos, M Puccioni-Sohler, A M V de Almeida, S Oliveira, C A Basilio De Oliveira, H Alvarenga, C M Poser, Optic neuromyelitis syndrome in Brazilian patients Journal of Neurology, Neurosurgery & Psychiatry. ,vol. 73, pp. 429- 435 ,(2002) , 10.1136/JNNP.73.4.429
S. F. Roemer, J. E. Parisi, V. A. Lennon, E. E. Benarroch, H. Lassmann, W. Bruck, R. N. Mandler, B. G. Weinshenker, S. J. Pittock, D. M. Wingerchuk, C. F. Lucchinetti, Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis Brain. ,vol. 130, pp. 1194- 1205 ,(2007) , 10.1093/BRAIN/AWL371
Kenji Yamasaki, Jun-Ichi Kira, Yuji Kawano, Takuro Kobayashi, Takayuki Kanai, Yasuhara Nishimura, Sho Matsushita, Kanehiro Hasuo, Shozo Tobimatsu, Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders Annals of Neurology. ,vol. 40, pp. 569- 574 ,(1996) , 10.1002/ANA.410400405
Sean J. Pittock, Brian G. Weinshenker, Claudia F. Lucchinetti, Dean M. Wingerchuk, John R. Corboy, Vanda A. Lennon, Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression Archives of Neurology. ,vol. 63, pp. 964- 968 ,(2006) , 10.1001/ARCHNEUR.63.7.964
Dean M Wingerchuk, Vanda A Lennon, Claudia F Lucchinetti, Sean J Pittock, Brian G Weinshenker, The spectrum of neuromyelitis optica Lancet Neurology. ,vol. 6, pp. 805- 815 ,(2007) , 10.1016/S1474-4422(07)70216-8
Vanda A Lennon, Dean M Wingerchuk, Thomas J Kryzer, Sean J Pittock, Claudia F Lucchinetti, Kazuo Fujihara, Ichiro Nakashima, Brian G Weinshenker, A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis The Lancet. ,vol. 364, pp. 2106- 2112 ,(2004) , 10.1016/S0140-6736(04)17551-X